Finding 574131 (2024-004)

Material Weakness
Requirement
B
Questioned Costs
-
Year
2024
Accepted
2025-08-21
Audit: 364705
Organization: Legacy Medical Care Inc. (IL)

AI Summary

  • Core Issue: There is a material weakness in internal controls over compliance, specifically regarding the lack of documentation for payroll cost approvals.
  • Impacted Requirements: The organization failed to meet the requirements outlined in § 200.303(a) for maintaining effective internal controls over federal awards.
  • Recommended Follow-Up: Ensure proper documentation is maintained to demonstrate that payroll review and approval processes are effectively functioning.

Finding Text

Finding 2024-004 – Allowable Costs Federal Agency: U.S. Department of Health and Human Services Federal Program Name: Grants for New and Expanded Services Under the Health Center Program Assistance Listing Number: 93.224/93.527 Federal Award Identification Number: L2C42352-01-00 Award Periods: July 1, 2021 – June 30, 2023. Type of Finding: Material weakness in internal control over compliance Criteria: § 200.303(a) indicates non-federal entities must establish, document and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States or the “Internal Control Integrated Framework”, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Condition: Lack of supporting documentation demonstrating management's review and approval of costs prior to being charged to the grant and drawn down. Questioned Costs: None. Context: This condition impact all of the payroll transactions selected for testing. Cause: Unknown Effect: Incorrect payroll costs could be charged to the grant. Repeat Finding: No. Recommendation: We recommend the Organization maintain documentation demonstrating that the existing payroll review and approval process in place is functioning. Views of Responsible Officials: There is no disagreement with the audit finding.

Corrective Action Plan

Action taken in response to finding: A new process has been put in place documenting the review and approval of payroll. Name(s) of the contact person(s) responsible for corrective action: Melissa D’Onorio, CEO, and Donna Landy, CFO. Planned completion date for corrective action plan: 07/14/2025

Categories

Allowable Costs / Cost Principles Material Weakness Matching / Level of Effort / Earmarking Internal Control / Segregation of Duties

Other Findings in this Audit

  • 574129 2024-002
    Material Weakness Repeat
  • 574130 2024-003
    Material Weakness Repeat
  • 574132 2024-005
    Significant Deficiency
  • 574133 2024-003
    Material Weakness Repeat
  • 574134 2024-005
    Significant Deficiency
  • 1150571 2024-002
    Material Weakness Repeat
  • 1150572 2024-003
    Material Weakness Repeat
  • 1150573 2024-004
    Material Weakness
  • 1150574 2024-005
    Significant Deficiency
  • 1150575 2024-003
    Material Weakness Repeat
  • 1150576 2024-005
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
21.027 Coronavirus State and Local Fiscal Recovery Funds $294,199
93.498 Provider Relief Fund and American Rescue Plan (arp) Rural Distribution $85,710
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $37,364
93.322 Cdc Partnership: Strengthening Public Health Laboratories $33,792
93.332 Cooperative Agreement to Support Navigators in Federally-Facilitated Exchanges $18,289
93.268 Immunization Cooperative Agreements $14,950
93.527 Grants for New and Expanded Services Under the Health Center Program $8,823